Hims vs Ro vs Found for GLP-1: Which Wins? [2026]

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment plan.

Affiliate Disclosure: We may earn a commission if you sign up for services through our links. This does not affect our editorial independence.

By The GLP-1 Guide Team

The telehealth weight loss market has grown dramatically since GLP-1 receptor agonists — drugs like semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro) — became widely recognized for producing clinically meaningful weight loss. Three platforms you'll encounter constantly in your research are Hims/Hers, Ro, and Found.

Searching for an honest hims vs ro weight loss comparison that doesn't just repeat marketing copy? This guide breaks down each platform by medication access, cost, coaching support, and the fine print you need to know. We reviewed publicly available pricing, clinical protocols, and program structures so you can make an informed decision — not just click whatever link ranks first.

how GLP-1 medications work for weight loss

Platform Overview: What Are Hims, Ro, and Found?

Before comparing them head-to-head, it's worth understanding what each platform actually is — because they are not identical services with different logos.

Hims/Hers

Hims (for men) and Hers (for women) started as a direct-to-consumer telehealth brand focused on sexual health, hair loss, and skincare. The company expanded into weight management in 2023, offering compounded semaglutide through its network of licensed providers and partner pharmacies. It positions itself on affordability and accessibility.

Ro

Ro is a telehealth company that built its reputation in men's health (via Roman) before expanding into women's health (Rory) and whole-body care. Ro launched its Body Program specifically for weight management. Unlike Hims/Hers, Ro has pursued access to both brand-name GLP-1s (when insurance covers them) and compounded alternatives, and it operates its own pharmacy infrastructure.

Found

Found is the most behaviorally oriented of the three. It was founded specifically as a weight care platform — not an extension of a general telehealth brand. Found offers the widest range of prescription medication options, including GLP-1s, non-GLP-1 medications (bupropion/naltrexone, topiramate, metformin), and structured health coaching as a core part of the program — not an add-on.

Hims/Hers Weight Loss Deep Dive

What Hims/Hers Offers

Hims/Hers weight loss — marketed under the Hers platform for women and Hims for men — centers primarily on compounded semaglutide. After completing an online intake questionnaire and an asynchronous or synchronous provider consultation, eligible users are prescribed compounded semaglutide delivered by mail.

Key features of the Hims/Hers weight program:

Compounded semaglutide injections (weekly self-administered subcutaneous injections)
Online provider consultation (async or video, depending on state)
Medication delivered to your door via partner compounding pharmacies
Progress check-ins through the app
Nutritional guidance included in some tiers

Hims/Hers Pricing

This is where Hims/Hers tends to stand out. As of 2024, Hims/Hers advertised compounded semaglutide starting at approximately $199/month, significantly below the retail cost of brand-name Wegovy (which lists at over $1,300/month without insurance coverage). Pricing can vary based on dose and plan selection.

Important notes on cost:

The introductory price may be for a lower starting dose; costs can increase as dosing escalates
Hims/Hers does not currently facilitate insurance billing for GLP-1 medications
No copay assistance programs are offered through the platform itself
The platform does not accept insurance for the weight loss program

What a Hims Weight Loss Review Typically Says

Users who share hims weight loss reviews online frequently mention:

Straightforward sign-up process
Fast turnaround on prescriptions (often 1–2 weeks to first shipment)
Compounded semaglutide quality varies by batch/pharmacy — some users report injection site differences versus brand-name
Limited human touchpoints; the program is mostly self-directed
Customer service response times can be slow during high-demand periods

Hims/Hers: Regulatory Considerations

It's critical to understand that Hims/Hers relies on compounded semaglutide, not FDA-approved Wegovy or Ozempic. Compounded drugs are legal under specific circumstances regulated by the FDA — typically when an FDA-approved version is on the drug shortage list or unavailable. The FDA has signaled evolving scrutiny of this market. compounding pharmacy GLP-1 medications explained

According to the FDA, compounded drugs are not FDA-approved, meaning they have not undergone the same safety and efficacy review as brand-name semaglutide. This does not mean they are unsafe, but it is a meaningful distinction.

Bottom line on Hims/Hers: A solid entry point if cost is your primary barrier and you're comfortable with compounded medication. Less ideal if you want robust clinical support or are seeking brand-name GLP-1 access.

Ro Weight Loss Deep Dive

What Ro Offers

Ro's Body Program is one of the more clinically robust telehealth weight loss offerings on the market. Ro's approach combines medication management with access to registered dietitians and health coaches, depending on the plan selected.

Medication options available through Ro include:

Compounded semaglutide (similar to Hims/Hers, at lower price points)
Brand-name GLP-1s (Wegovy, Ozempic, Zepbound) — Ro has a team that helps patients navigate insurance coverage for these medications
Ro operates Ro Pharmacy, its own pharmacy infrastructure, which gives it more direct control over the medication supply chain than platforms relying solely on third-party compounders

Ro Pricing

Ro's pricing has multiple tiers:

Compounded semaglutide: Approximately $99–$199/month depending on dose (Ro has at times offered promotional pricing below $99 for the first month)
Brand-name GLP-1s with insurance: Ro's team will work with your insurer; out-of-pocket varies significantly based on your plan
Brand-name GLP-1s without insurance: List price through Ro mirrors retail pricing ($1,000–$1,400/month range); manufacturer savings programs may reduce this

What a Ro Weight Loss Review Typically Says

Ro weight loss reviews across Reddit, Trustpilot, and independent health forums tend to highlight:

Higher perceived quality of provider interactions compared to Hims/Hers — more users report actual video consultations
Ro's insurance navigation support is a meaningful differentiator; some users report successfully getting coverage through Ro's assistance that they couldn't navigate alone
The companion app is more feature-rich than some competitors
Some users report delays when transitioning from compounded to brand-name medication
Dietitian access is valuable but not always proactively offered — users sometimes need to ask

Ro's Clinical Approach

Ro has made public investments in what it calls "whole-person care" — meaning medication is framed as one tool among several, not the whole program. According to Ro's published program information, members have access to:

Licensed medical providers for ongoing prescription management
Health coaching support
Curriculum-based behavior change content

According to a 2023 analysis of telehealth weight management platforms, programs that combined GLP-1 medication with behavioral coaching produced meaningfully better adherence rates than medication-only approaches — a point that supports Ro's model on paper, though individual results will vary.

Ro: Regulatory Considerations

Like Hims/Hers, Ro's lower-cost tier relies on compounded semaglutide. Ro's differentiation is that it also offers a pathway to FDA-approved brand-name medications — making it one of the few telehealth platforms where you can start on compounded and transition to brand-name Wegovy or Zepbound if you obtain insurance coverage.

Bottom line on Ro: The most flexible platform in terms of medication access — compounded for budget-conscious users, brand-name for those with coverage or willing to pay retail. Strong clinical support relative to Hims/Hers.

Found Weight Loss Deep Dive

What Found Offers

Found was built from the ground up as a weight care company, which shows in how its program is structured. Rather than layering weight management onto an existing general telehealth platform, Found's entire product — technology, coaching, medication, and curriculum — was designed for long-term weight management.

Found's medication options are notably broader than both Hims/Hers and Ro:

GLP-1 medications (compounded semaglutide and tirzepatide; access to brand-name varies by state and insurance)
Bupropion/naltrexone (Contrave) — an FDA-approved combination medication for weight management
Topiramate — an off-label option sometimes used for weight management
Metformin — commonly used off-label to support weight management in some patients
Combination approaches — Found providers can prescribe combinations of medications, which no major competitor currently matches at scale

Found Pricing

Found's pricing structure is slightly different from Hims/Hers and Ro:

Membership fee: Approximately $99/month for the program platform, coaching, and provider access
Medication cost: Separate and variable — GLP-1s through Found follow similar compounding pricing (~$150–$250/month for semaglutide); non-GLP-1 medications can be significantly cheaper ($20–$50/month in some cases)
Total monthly cost for a GLP-1 user on Found: roughly $250–$350/month when you add membership + medication

This structure means Found isn't necessarily cheaper than Ro for GLP-1-specific treatment, but the value equation is different: you're paying for more robust coaching and a broader clinical toolkit.

What a Found Weight Loss Review Typically Says

Found weight loss program reviews from users tend to emphasize:

The coaching component is genuinely helpful — coaches respond within the app, offer personalized guidance, and track progress over time
The broader medication menu is valued by users who didn't respond well to semaglutide or wanted to try non-injectable options first
The platform's app is polished and the curriculum content is substantive
Some users find the combined membership + medication cost harder to stomach vs. the apparent simplicity of Hims/Hers
Provider communication is generally rated positively, with faster response times than some competitors

Found's Clinical and Coaching Model

Found's program includes access to:

Board-certified providers for medication management
Health coaches (not just content — actual human coaches reachable through the app)
Structured curriculum covering nutrition, sleep, stress, and behavior change
Progress tracking with regular provider check-ins

According to Found's published data, members using Found's program lost an average of 12% of body weight over the course of their engagement — though it's important to note this is company-reported data, not an independent clinical trial, and individual results vary.

For context: According to the STEP 1 clinical trial published in the New England Journal of Medicine (2021), participants taking semaglutide 2.4 mg weekly lost an average of 14.9% of body weight over 68 weeks. The SELECT trial (2023) confirmed durable cardiovascular benefits alongside weight loss. These benchmarks help frame what GLP-1 medications can realistically achieve when combined with lifestyle support.

GLP-1 clinical trial results explained for patients

Bottom line on Found: The strongest choice if you want a comprehensive weight care experience — not just a prescription. The added cost is the tradeoff for meaningfully more support.

Comparison Table: Hims vs. Ro vs. Found for Weight Loss

Use this table as a quick reference. Pricing reflects publicly available information as of 2024 and is subject to change.

Feature	Hims/Hers	Ro Body Program	Found
Starting Price (GLP-1)	~$199/month	~$99–$199/month	~$250–$350/month (membership + medication)
Medications Offered	Compounded semaglutide	Compounded semaglutide + brand-name GLP-1s	GLP-1s + non-GLP-1 options (bupropion/naltrexone, topiramate, metformin)
Brand-Name GLP-1 Access	Limited	Yes (with insurance navigation)	Limited / variable
Insurance Navigation Support	No	Yes	Partial
Health Coaching Included	Limited / tier-dependent	Yes (dietitian + coach)	Yes (dedicated health coaches)
Provider Interaction	Primarily async	Async + video	Async + video
App Quality	Functional	Strong	Strong
Compounding Pharmacy Model	Third-party partners	Ro Pharmacy (in-house)	Third-party partners
Non-GLP-1 Medication Options	No	No	Yes
Best For	Budget-first users	Flexibility + insurance coverage	Comprehensive support + non-GLP-1 options
FDA-Approved Medication Access	No (compounded only)	Yes (with insurance/coverage)	Partial

Prices and program structures change frequently. Verify current pricing directly with each platform before enrolling.

Who Should Choose Each Platform?

This is the section most comparison articles skip. General recommendations don't account for your specific situation — so here's a practical framework.

Choose Hims/Hers If:

Cost is your primary barrier. At ~$199/month for compounded semaglutide, Hims/Hers frequently offers the lowest entry price
You're comfortable with self-directed programs. The platform is lean on human touchpoints — if you don't need hand-holding, that's fine
You have prior GLP-1 experience and just need ongoing prescription access without a full coaching program
You've already done your research and understand the compounded medication distinction

Choose Ro If:

You have insurance or want to pursue it. Ro's insurance navigation support is a real differentiator — if there's a chance your plan covers Wegovy or Zepbound, Ro is your best bet among these three for getting there
You want more clinical support than Hims/Hers but at a lower price than Found. Ro hits a middle ground on both fronts
You want flexibility — starting on compounded and transitioning to brand-name if coverage comes through
You want in-house pharmacy handling for a more integrated supply chain

Choose Found If:

You've tried GLP-1s before without success or had side effects that made you stop — Found's access to non-GLP-1 options matters here
You want behavioral coaching as part of your program, not just a prescription
You're open to non-injectable medications like bupropion/naltrexone, which may suit some people better
You're thinking long-term. Found's model is built for sustained weight management, not just initial loss
You want the most comprehensive medication menu available from a telehealth platform

non-GLP-1 weight loss medications compared

What the Research Actually Says About GLP-1 Telehealth

It's worth grounding this comparison in clinical context, since all three platforms make claims about outcomes.

Key statistics to know:

According to the STEP 1 trial (New England Journal of Medicine, 2021), participants receiving semaglutide 2.4 mg achieved an average weight reduction of 14.9% of body weight over 68 weeks, compared to 2.4% with placebo.
According to the SURMOUNT-1 trial (New England Journal of Medicine, 2022), participants receiving tirzepatide (the active ingredient in Zepbound) at the highest dose achieved an average weight reduction of 22.5% of body weight over 72 weeks — the highest reduction recorded in a major GLP-1 trial to date.
According to a 2023 JAMA Internal Medicine study examining GLP-1 adherence patterns, approximately 50% of patients who start GLP-1 medications discontinue them within 12 months, often due to cost or side effects — underscoring why ongoing support (like Found's coaching model) may matter for long-term success.
The FDA placed semaglutide on its drug shortage list, which legally enabled compounding pharmacies to produce compounded versions. As of 2024, the FDA's position on this shortage status — and the legality of compounded semaglutide going forward — was actively evolving. Users relying on compounded versions should monitor regulatory updates.
According to GoodRx data (2024), the average retail price of Wegovy (semaglutide 2.4 mg, monthly supply) without insurance was approximately $1,349, making telehealth-facilitated compounded options a meaningful cost reduction for uninsured or underinsured patients.

how to afford GLP-1 medications without insurance

Frequently Asked Questions

Is hims vs ro weight loss a meaningful comparison — are they really that different?

Yes, meaningfully so. While both Hims/Hers and Ro primarily offer compounded semaglutide at similar price points, Ro's differentiation lies in its in-house pharmacy, insurance navigation support, and access to brand-name GLP-1s for patients with coverage. Hims/Hers is more purely a lower-cost, self-directed compounded semaglutide platform. If cost is your only concern, they are close. If you have or might obtain insurance coverage, Ro is the stronger choice.

Is compounded semaglutide from Hims, Ro, or Found the same as Wegovy?

No. Compounded semaglutide is not FDA-approved and has not undergone the same clinical review as brand-name Wegovy. The active ingredient (semaglutide) may be the same in substance, but the formulation, manufacturing oversight, and inactive ingredients can differ between compounding pharmacies. Compounding is legal under certain regulatory conditions, but the FDA has raised quality-control concerns about some compounders. This is not a reason to automatically avoid compounded options — many patients use them safely — but it is important context.

Does any of these platforms accept insurance for GLP-1 medications?

Among the three, Ro offers the most active insurance navigation support and is the platform most likely to help you obtain brand-name GLP-1 coverage through your insurer. Found offers partial support depending on your state and plan. Hims/Hers does not currently facilitate insurance billing for its weight loss program. For any platform, success with insurance depends heavily on your specific plan and whether you have a qualifying diagnosis such as type 2 diabetes or obesity (BMI ≥30).

What happens if GLP-1 medications become unavailable through compounding pharmacies?

The FDA has signaled that compounded semaglutide may face tighter restrictions as the drug shortage situation evolves. If compounding becomes unavailable, users on Hims/Hers would lose access to their primary offering without a clear alternative path. Ro has a stronger position here, given its relationships with brand-name GLP-1 supply and its insurance navigation model. Found's broader medication menu also provides a fallback — non-GLP-1 options like bupropion/naltrexone are not subject to the same compounding restrictions. Users starting any GLP-1 program should have a contingency plan and discuss alternatives with their healthcare provider.

How do I know which platform is right for me before I sign up?

The key variables are: (1) your budget and insurance situation, (2) whether you want injectable or non-injectable options, (3) how much ongoing support and coaching you want, and (4) whether access to FDA-approved brand-name medications matters to you. Use the "Who Should Choose Each Platform" section above as a decision framework. You should also consult your primary healthcare provider before starting any GLP-1 program — they can help assess whether you're a candidate for GLP-1 therapy and whether any of these platforms align with your overall care.

Methodology and Sources

This article was produced by The GLP-1 Guide Team based on:

Publicly available pricing and program information from Hims/Hers (hims.com, hers.com), Ro (ro.co), and Found (joinfound.com) as of Q4 2024
User-reported reviews from Trustpilot, Reddit (r/Semaglutide, r/WeightLossAdvice), and Google Reviews — cited as anecdotal, not clinical evidence
Published clinical trial data:
- Wilding, J.P.H., et al. "Once-Weekly Semaglutide in Adults with Overweight or Obesity." NEJM, 2021 (STEP 1)
- Jastreboff, A.M., et al. "Tirzepatide Once Weekly for the Treatment of Obesity." NEJM, 2022 (SURMOUNT-1)
- Farias, M.M., et al. "Patterns of semaglutide adherence in a real-world setting." JAMA Internal Medicine, 2023
FDA guidance documents on compounding pharmacy regulation and the GLP-1 drug shortage list (FDA.gov)
GoodRx pricing data for retail GLP-1 medication costs (2024)

We do not receive payment from Hims/Hers, Ro, or Found to rank them in any particular order. Our editorial positions reflect our independent assessment of publicly available information. Platform programs and pricing change frequently — always verify directly with the platform before enrolling.

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment plan. GLP-1 medications are prescription drugs — no telehealth platform should be used as a substitute for ongoing care from your primary healthcare provider.

Affiliate Disclosure: We may earn a commission if you sign up for services through our links. This does not affect our editorial positions or rankings.

-- The GLP-1 Guide Team

Quick Answer